文献速递主动脉外科

人主动脉组织靶向测序揭示未诊断的遗传性胸主动脉疾病

Targeted Sequencing of Human Aorta Tissue Reveals Undiagnosed Heritable Thoracic Aortic Disease.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

本研究利用单中心生物样本库的人主动脉组织进行靶向二代测序,纳入134例疑似遗传性胸主动脉疾病(HTAD)患者。结果发现27例(20.1%)携带变异,最终17例(12.7%)获得额外HTAD诊断,表明主动脉组织基因组分析可解决临床与基因组数据的不一致。

要点

  • 对疑似HTAD患者主动脉组织行96基因靶向测序可提高诊断率。
  • 134例中27例(20.1%)检出变异,17例(12.7%)获额外HTAD诊断。
  • 检出变异涉及FBN1、MYH11、COL11A1、SMAD3等12个基因。

核心结论

  • 人主动脉组织基因组分析可额外诊断未识别的HTAD,有助于解决临床与基因组数据的不一致。

研究设计与样本

  • 单中心生物样本库研究,2016年5月至2021年11月共622例胸主动脉瘤或急性主动脉综合征手术患者捐献样本,其中134例疑似HTAD的主动脉组织被取回分析。
  • 纳入标准包括家族史、年龄≤45岁、主动脉环扩张、二叶主动脉瓣、动脉导管未闭、多囊肾病或既往胚系测序分类为意义不明变异(n=17)。
  • 排除既往胚系测序分类为可能致病或致病的患者,靶向 panel 包含96个基因。

主要发现

  • 共鉴定29个变异,涉及FBN1、MYH11、COL11A1、SMAD3、SMAD6、ACTA2、COL3A1、FLNA、PKD2、THSD4、ACVRL1和FBN2。
  • 27例患者(20.1%)携带变异,其中2例为双基因变异。
  • 结合临床与遗传数据,最终17例患者(12.7%)获得额外HTAD诊断。

临床怎么用

  • 对疑似HTAD且既往胚系测序意义不明或未确诊的患者,可考虑利用手术获取的主动脉组织行靶向基因组分析以辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To diagnose undiagnosed heritable thoracic aortic disease (HTAD) using targeted next-generation sequencing technology on human aorta tissue obtained from a single-centre biobank. METHODS: From May 2016 to November 2021, 622 patients undergoing surgical repair for thoracic aortic aneurysm or acute aortic syndrome donated blood or tissue samples to the research biobank. A total of 134 aortic tissue samples were retrieved from patients suspected of HTAD. The inclusion criteria were (1) family history, (2) age ≤ 45, (3) annuloaortic ectasia, (4) bicuspid aortic valve, (5) patent ductus arteriosus, (6) polycystic kidney disease, or (7) patients previously classified as variant of uncertain significance by germline sequencing (n = 17). Exclusion criteria included patients previously classified as likely pathogenic or pathogenic by germline sequencing. The targeted panel included 96 genes. RESULTS: A total of 29 variants were identified including FBN1, MYH11, COL11A1, SMAD3, SMAD6, ACTA2, COL3A1, FLNA, PKD2, THSD4, ACVRL1, and FBN2. A total of 27 patients (20.1%) had variants with 2 patients having digenic variants. Clinical data were combined with genetic data, and finally, 17 patients (12.7%) were additionally diagnosed with HTAD. CONCLUSIONS: Genomic data analysis of human aortic tissue allowed for additional diagnoses of undiagnosed HTAD, contributing to resolving discrepancies between clinical and genomic data. Considering the surgical treatment of HTAD, human aortic tissue can be a valuable resource for genomic analysis.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lee H, Kim Y, Kim MS, et al. Targeted Sequencing of Human Aorta Tissue Reveals Undiagnosed Heritable Thoracic Aortic Disease. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41999216. doi:10.1093/icvts/ivag102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。